BrainMD, the leading brain health supplement company founded by psychiatrist and brain health expert Daniel G. Amen, MD, announced the launch of Happy Saffron Plus® Gummies, a delicious new format...

Stryker a global leader in medical technologies, announced the U.S. commercial launch of Mako RPS® (Robotic Power System) for total knee replacement procedures, further expanding the Mako portfolio into...

Slumber, maker of Deep Zzzs and Pure Sleep™, announced three additions to its sleep portfolio: Magnesium Glycinate, a more potent Extra Strength Deep Zzzs, and a new THC-free Deep Zzzs formula, all...

Cognito Therapeutics, a clinical-stage neurotechnology company developing novel therapies for neurodegenerative disorders, announced the presentation of new exploratory biomarker data at the...

HistoSonics, announced that the company has received CE Mark approval in Europe for its Edison® System, enabling commercialization of the company’s non-invasive histotripsy technology in Europe and other...

Egg Medical, a leader in Enhanced Radiation Protection Devices (ERPDs) for interventional procedures, announced the official launch of EggNest Complete 2.0, the latest evolution of the advanced...

MedStar Health hand surgeons in both D.C. and Baltimore became the first in their respective regions to perform a break-through treatment for patients living with debilitating thumb carpometacarpal...

Beckman Coulter Diagnostics, a global leader in clinical diagnostics and a Danaher company, announced it received CE Mark under IVDR for its Access p-Tau217 assay, a blood test designed to support...

Reprotech announced that the TMRW Vault® has received CE marking as a Class IIa medical device under Regulation (EU) 2017/745, supporting commercialization in the European Union and other...

Reprotech announced that the TMRW Vault® has received CE marking as a Class IIa medical device under Regulation (EU) 2017/745, supporting commercialization in the European Union and other...

Jiahui International Cancer Center (JICC) has welcomed the world's first international patient to begin treatment with Satri-cel, the world's first approved CAR-T therapy for a solid tumor, marking a...

Jiahui International Cancer Center (JICC) has welcomed the world's first international patient to begin treatment with Satri-cel, the world's first approved CAR-T therapy for a solid tumor, marking a...